Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site

The serine/threonine kinase, GSK-3, is a promising drug discovery target for treating multiple pathological disorders. Most GSK-3 inhibitors that were developed function as ATP competitive inhibitors, with typical limitations in specificity, safety and drug-induced resistance. In contrast, substrate...

Descripción completa

Detalles Bibliográficos
Autores principales: Rippin, Ido, Khazanov, Netaly, Ben Joseph, Shirley, Kudinov, Tania, Berent, Eva, Arciniegas Ruiz, Sara Melisa, Marciano, Daniele, Levy, Laura, Gruzman, Arie, Senderowitz, Hanoch, Eldar-Finkelman, Hagit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698860/
https://www.ncbi.nlm.nih.gov/pubmed/33218072
http://dx.doi.org/10.3390/ijms21228709

Ejemplares similares

Ejemplares similares